MassBio General Counsel Executive Group Roundtable: Corporate Governance at Small- and Mid-Cap Life Sciences Companies

MassBio General Counsel Executive Group Roundtable: Corporate Governance at Small- and Mid-Cap Life Sciences Companies

Speaking Engagement

WilmerHale Partners Lia Der Marderosian and Jonathan Wolfman presented to MassBio's General Counsel Executive Group at their quarterly roundtable event series on the topic “Corporate Governance at Small- and Mid-Cap Life Sciences Companies."

While a significant disparity continues to exist between the governance practices of large-cap vs. other public companies, mid- and small-cap companies are under increased scrutiny as a result of several legal and regulatory factors. Lawyers from WilmerHale discussed evolving standards and trend data with respect to governance issues that are typically raised by institutional shareholders with mid- and small-cap life sciences companies.

Read More About the Event

Speakers